Showing results (91-100 of 419) with videos related to
Sort By:
Pageof 42
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapyChien-Chung Chang, Michael Campoli, Nicholas P Restifo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2003
Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patientsTakeshi Ogino, Nobuyuki Bandoh, Tatsuya Hayashi, et al.Cancer Biology & Therapy|December 19, 2007
Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodiesElena Signorino, Davide Brusa, Riccarda Granata, et al.Cancer Letters|September 3, 2017
A novel chemoradiation targeting stem and nonstem pancreatic cancer cells by repurposing disulfiramJuan Cong, Yangyang Wang, Xiao Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and impairs HLA class I-restricted antigen presentationFabio Morandi, Emma Di Carlo, Soldano Ferrone, et al.Journal of the National Cancer Institute|February 7, 2016
Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant MelanomaFrancesco Sabbatino, Yangyang Wang, Giosuè Scognamiglio, et al.Cancer Treatment and Research|October 11, 2005
Mechanisms of tumor evasionMichael Campoli, Soldano Ferrone, Arnold H Zea, et al.Plos One|February 15, 2013
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cellsBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.International Journal of Cancer|February 2, 2006
Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?Sandra R Reynolds, Irene J Vergilis, Michael Szarek, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2006
CD4-dependent potentiation of a high molecular weight-melanoma-associated antigen-specific CTL response elicited in HLA-A2/Kb transgenic miceLiaomin Peng, Eric Ko, Wei Luo, et al.Pageof 42